Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean lactam acid l and arabic montana and zinc oxide?
Displaying drugs 15126 - 15150 of 15185 in total

Propiopromazine

Experimental
Vet approved

ING-1

ING-1 is a high-affinity, human engineered trade mark monoclonal antibody that recognizes a 40 kilodalton epithelial cell adhesion molecule (EpCAM) glycoprotein that is expressed in high levels on most adenocarcinomas. It is an attractive target for immunotherapy.
Investigational

R-348

Investigational

Amitifadine

Investigational

RG-7795

Investigational

R450

R450 is an alpha 1 antagonist that acts to tighten the muscle tone in the bladder. It is being considered for treatment of stress-related urinary incontinence. Phase IIa data for the drug show it reduced the number of incontinent episodes compared to placebo with minimal cardiovascular effects.
Investigational

2-Nitro-4-cresol

Experimental

IMIDAZOPYRIDAZIN 1

Experimental

{4-Amino-2-[(4-methoxyphenyl)amino]-1,3-thiazol-5-yl}(4-methoxyphenyl)methanone

Experimental

PF-04447943

PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational

Alamifovir

Alamifovir is an antiviral agent specific for HBV.
Investigational

[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL

Experimental

FavId

FavId, is an active immunotherapy that is based upon unique genetic information extracted from a patient's tumor.
Investigational

Dihydroquinidine barbiturate

Experimental

Vestipitant

Vestipitant has been investigated for the treatment of Tinnitus.
Investigational

R1295

R1295 is an integrin antagonist currently in clinical trials for the treatment of rheumatoid arthritis. Integrins are associated to the pathology seen in some of the autoimmune diseases such as rheumatoid arthritis.
Investigational

Zanapezil

Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational

(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine

Experimental

[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone

Experimental

Albaconazole

Albaconazole has been used in trials studying the basic science of Onychomycosis.
Investigational

Oxyfedrine

Experimental

P-Nitrophenol

Experimental

3-(4-nitrophenyl)-1H-pyrazole

Experimental

ISIS 113715

ISIS 113715 is our second-generation antisense inhibitor of protein tyrosine phosphatase 1b, or PTP‑1b, for the treatment of type 2 diabetes. In early trials, ISIS 113715 induced statistically significant improvements in multiple measures of glucose control along with statistically significant reductions in LDL-cholesterol.
Investigational

ICA-105665

ICA-105665 is a novel small molecule compound for the treatment of epilepsy. It is a novel opener of the KCNQ ion channel which in preclinical studies has demonstrated a broad spectrum of activity in models of epilepsy. In addition, ICA-105665 has also demonstrated activity in certain models of neuropathic pain.
Investigational
Displaying drugs 15126 - 15150 of 15185 in total